Possible Treatment of Myocardial Infarct Based on Tissue Engineering Using a Cellularized Solid Collagen Scaffold Functionalized with Arg-Glyc-Asp (RGD) Peptide

Currently, the clinical impact of cell therapy after a myocardial infarction (MI) is limited by low cell engraftment due to low cell retention, cell death in inflammatory and poor angiogenic infarcted areas, secondary migration. Cells interact with their microenvironment through integrin mechanorece...

Descripción completa

Detalles Bibliográficos
Autores principales: Schussler, Olivier, Falcoz, Pierre E., Chachques, Juan C., Alifano, Marco, Lecarpentier, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620820/
https://www.ncbi.nlm.nih.gov/pubmed/34830447
http://dx.doi.org/10.3390/ijms222212563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620820/
https://www.ncbi.nlm.nih.gov/pubmed/34830447
http://dx.doi.org/10.3390/ijms222212563

Ejemplares similares